Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.
Patients who have drug-resistant tuberculosis have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine.
Mario Herrero, a professor in the Department of Global Development and a Cornell Atkinson Scholar, has been appointed to the EAT-Lancet 2.0 leadership team to spearhead the modeling workstream.
The financial stability of providers and their ability to serve patients is being threatened by Wall Street, according to new research co-authored by ILR Professor Rose Batt.
A new study – using lab mice genetically modified with a human gene to shed light on a potential link between arsenic exposure and diabetes – revealed that while the male mice exposed to arsenic in drinking water developed diabetes, the female mice did not.
Researchers from Weill Cornell Medicine have provided the first national estimate of caregivers’ pain and arthritis experiences that can limit their ability to perform necessary tasks while caring for older family members.
In this episode of the Inclusive Excellence Podcast, Erin Sember-Chase and Toral Patel invite C Lucas, wellness community programming specialist at Cornell, for a conversation about the challenges and complexities that exist in the fitness industry.
While world public health agencies are focused on how to react to the next pandemic once it has started, a new plan proposes using ecological perspectives to prevent disease outbreaks before they happen.
Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.